45 kcal% High Fat Diet
45 kcal% High Fat Diet is a high-fat model diet used to establish animal models of obesity and type 2 diabetes. Designed with similarities to Research Diets, Inc.formula D12451.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Induced Disease Models
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.
45 kcal% High Fat Diet can be used to establish animal models of obesity and type 2 diabetes[1][2][3].
Administration: fed • every day for 15 weeks.
Mice: C57BL/6J • male • one-month-old
Administration: fed • every day for 5 months.
1) A 24-hour fasting method or a 7-day gradual diet change is recommended for diet changes.
2) Change the diet every 2-3 days, discarding old feed.
3) Wood shavings are preferred as bedding, changing 1-2 times weekly.
4) Store refrigerated.
Serum Biochemistry: Glucose level, AST and ALT are increased in the HF diet group. Fat metabolism markers, including T-CHO, TG, HDL-cholesterol, LDL-cholesterol and FFA, are increased significantly.
Histopathology: Cytoplasmic microvacuolation of centrilobular hepatocytes is observed more frequently in the HF diet rats. Mild inflammatory infiltration of neutrophils and mononuclear cells, fibrosis and severe hepatocellular ballooning degeneration are observed.
Other indicators: The HF diet rats consistently exceeded the normal diet group in liver and fat pad weights.
Administration: fed • every day for 4 weeks.
1) A 24-hour fasting method or a 7-day gradual diet change is recommended for diet changes.
2) Rats fed with high-fat diet after four weeks are injected with a single dose of Streptozotocin (STZ) (30 mg/kg) intraperitoneally (i.p.) following overnight fasting.
3) Rats with the blood glucose taken from the tail vein over 16.7 mM at 7 and 14 days post-injection are considered diabetic.
.
Blood glucose level: An oral glucose tolerance test (OGTT) is impaired in diabetic rats.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Color Pink to red
-
SMILES
[45 kcal% High Fat Diet]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Ha SK, et al. Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats. J Comp Pathol. 2011 Jul;145(1):88-94. [Content Brief]
[2]. Han J, et al. High-Fat Diet-Induced Weight Gain, Behavioral Deficits, and Dopamine Changes in Young C57BL/6J Mice. Front Nutr. 2021 Jan 20;7:591161. [Content Brief]
[3]. Zhang D, et al. Hesperetin-Enhanced Metformin to Alleviate Cognitive Impairment via Gut-Brain Axis in Type 2 Diabetes Rats. Int J Mol Sci. 2025 Feb 23;26(5):1923. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)